Articles citing this paper

Radiolabelled Peptides: Optimal Candidates for Theranostic Application in Oncology

Andrew J. Hall ^A and Mohammad B. Haskali

^A ^B ^C

+ Author Affiliations

- Author Affiliations

^A Radiopharmaceutical Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, Vic. 3000, Australia.

^B Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Vic. 3010, Australia.

^C Corresponding author. Email: mo.haskali@petermac.org

Dr Mohammad Haskali is a radiopharmaceutical scientist (RPS) certified by the Australasian College of Physical Scientists and Engineers in Medicine in their A1 limited category. After receiving his PhD degree in the development of research radiopharmaceuticals and radiochemistry methodologies, he gained extensive experience in the radiopharmaceutical industry operating under the code of Good Manufacturing Practice (GMP) before joining the National Institute of Mental Health (NIMH) in the USA as a radiochemist. Currently, Dr Haskali is employed by the Peter MacCallum Cancer Centre in Melbourne where he is involved in radiopharmaceutical science research and the provision of radiopharmaceuticals for clinical use.

Australian Journal of Chemistry 75(2) 34-54 https://doi.org/10.1071/CH21118
Submitted: 20 May 2021 Accepted: 21 September 2021 Published: 8 November 2021

5 articles found in Crossref database.

Synthesis of a Bifunctional Cross‐Bridged Chelating Agent, Peptide Conjugation, and Comparison of 68Ga Labeling and Complex Stability Characteristics with Established Chelators

Damerow Helen, Wängler Björn, Schirrmacher Ralf, Fricker Gert, Wängler Carmen

ChemMedChem. 2023 18(1).

[Crossref]

Copper-Mediated Radiocyanation of Unprotected Amino Acids and Peptides

Sharninghausen Liam S., Preshlock Sean, Joy Stephen T., Horikawa Mami, Shao Xia, Winton Wade P., Stauff Jenelle, Kaur Tanpreet, Koeppe Robert A., Mapp Anna K., Scott Peter J. H., Sanford Melanie S.

Journal of the American Chemical Society. 2022 144(16). p.7422

[Crossref]

Preclinical Research Highlighting Contemporary Targeting Mechanisms of Radiolabelled Compounds for PET Based Infection Imaging

Kleynhans Janke, Sathekge Mike Machaba, Ebenhan Thomas

Seminars in Nuclear Medicine. 2023 53(5). p.630

[Crossref]

A Historical Review of Brain Drug Delivery

Pardridge William M.

Pharmaceutics. 2022 14(6). p.1283

[Crossref]

Development of Highly Potent Clinical Candidates for Theranostic Applications against Cholecystokinin-2 Receptor Positive Cancers

Corlett Alicia, Pinson Jo-Anne, Rahimi Marwa N., Zuylekom Jessica Van, Cullinane Carleen, Blyth Benjamin, Thompson Philip E., Hutton Craig A., Roselt Peter D., Haskali Mohammad B.

Journal of Medicinal Chemistry. 2023 66(15). p.10289

[Crossref]